University of Tennessee Health Science Center's Jonathan Wall Receives $1.79 Million to Develop New Amyloidosis Treatment
March 17, 2021
March 17, 2021
MEMPHIS, Tennessee, March 17 (TNSRes) -- The University of Tennessee Health Science Center issued the following news:
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center's Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled "Developing a Theranostic Immunotherapy for Systemic Amyloidosis."
Amyloidosis is a r . . .
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center's Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled "Developing a Theranostic Immunotherapy for Systemic Amyloidosis."
Amyloidosis is a r . . .